查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1636000

2025-2033 年按产品、测试类型（酶联免疫吸附测定、临床实验室改进修正案等）、应用和地区分類的骨骼和矿物质诊断测试市场报告

Bone and Mineral Diagnostic Testing Market Report by Product, Test Type (Enzyme-Linked Immunosorbent Assay, Clinical Laboratory Improvement Amendments, and Others), Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球骨骼和矿物质诊断检测市场规模达11IMARC Group美元。骨骼相关疾病发生率的大幅增加、对早期疾病诊断和预防的需求不断增加以及自动化检测技术的不断进步是推动市场的一些关键因素。

骨骼和矿物质诊断测试可检测骨骼和矿物质疾病，这些疾病使用 ELISA、CLIA 和 RIA 等技术进行，以诊断和评估治疗反应。骨骼和矿物质代谢紊乱是一个通用术语，用于描述由于钙、磷和维生素D 等矿物质缺乏而导致骨骼衰弱的一系列病症。并且需要最少的时间。使用 X 光、电脑断层扫描 (CT) 扫描或磁振造影 (MRI) 可以帮助识别或排除骨折、磨损和异常骨骼位置。此外，骨密度测试（也称为骨密度测定或骨密度测定）和骨扫描（骨闪烁扫描）可检测骨骼中的矿物质、骨代谢的详细信息，并描绘不同的骨骼结构。除此之外，骨骼活检和骨髓活检也是骨骼诊断测试的重要形式，其中使用细针去除骨组织以检测与疾病相关的变化。

骨骼和矿物质诊断测试市场趋势：

全球骨相关疾病发生率的大幅增加是推动市场的重要因素。这可以归因于久坐的生活方式导致维生素 D 缺乏的现像日益普遍。此外，自动化检测技术的不断进步，增强了诊断测试的能力，缩短了周转时间，提高了产出的准确性，正在为市场创造利润丰厚的成长机会。然而，几种骨诊断测试的成本增加、报销有限以及检测能力有限是限制市场成长的重要因素。相反，广泛的现场护理 (POC) 诊断测试的扩展以及公众对预防性医疗保健意识的大幅提高正在为市场创造积极的前景。政府和非营利组织为提高大众对各种诊断测试程序的认识而采取的有利倡议进一步推动了市场。除此之外，越来越多的老年人口更容易罹患这些疾病，导致骨骼疾病的发生率不断增加。促进市场发展的其他一些因素包括快速城市化、医疗支出增加、製造商推出新产品以及广泛的研发 (R&D) 活动。

本报告回答的关键问题：

  • 迄今为止，全球骨骼和矿物质诊断测试市场的表现如何，未来几年将如何表现？
  • 全球骨骼和矿物质诊断测试市场的驱动因素、限制因素和机会是什么？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的骨骼和矿物质诊断测试市场？
  • 基于产品的市场区隔是什么？
  • 根据测试类型，市场的细分是什么？
  • 基于应用程式的市场区隔是什么？
  • 全球骨骼和矿物质诊断检测市场的竞争结构如何？
  • 全球骨骼和矿物质诊断测试市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球骨骼和矿物质诊断测试市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 化验/耗材
    • 市场趋势
    • 市场预测
  • 仪器仪表
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按测试类型

  • 酵素连结免疫吸附测定法 (ELISA)
    • 市场趋势
    • 市场预测
  • 临床实验室改进修正案 (CLIA)
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 维生素 D 测试
    • 市场趋势
    • 市场预测
  • 骨代谢
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • bioMerieux SA
    • DiaSorin SpA
    • Epitope Diagnostics Inc.
    • F. Hoffmann-La Roche AG
    • QuidelOrtho Corporation
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112024A7106

The global bone and mineral diagnostic testing market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.48% during 2025-2033. A considerable increase in the incidences of bone-related diseases, the escalating demand for early disease diagnosis and prevention, and continual technological advancements in the automation of assay represent some of the key factors driving the market.

Bone and mineral diagnostic tests detect bone and mineral disorders that are performed using technologies, such as ELISA, CLIA, and RIA, to diagnose and assess treatment response. A bone and mineral metabolism disorder is a general term used to describe a range of conditions that can weaken bones due to mineral deficiencies like calcium, phosphorus, and vitamin D. In most cases, these tests are non-invasive, painless, and require minimal medication or administration, and several bone and mineral diagnostic tests are often performed using a combination method. The use of X-rays, computed tomography (CT) scans, or magnetic resonance imaging (MRI) can help identify or rule out fractures, wear and tear, and abnormal bone positions. Additionally, bone density tests (also known as bone densitometry or osteodensitometry) and bone scans (bone scintigraphy) detect the minerals in the bones, details on bone metabolism, and depict the different bone structures. Besides this, bone biopsies and bone marrow biopsies are also important forms of bone diagnostic testing, in which a thin needle is used to remove bone tissue to detect disease-related changes.

Bone and Mineral Diagnostic Testing Market Trends:

A considerable increase in the incidences of bone-related diseases on the global level is a significant factor driving the market. This can be attributed to the rising prevalence of sedentary lifestyle leading to deficiency of vitamin D. In line with this, the escalating demand for early disease diagnosis and prevention is also resulting in a higher uptake of various tests among the masses. Moreover, continual technological advancements in the automation of assay for enhanced diagnostic testing with lower turnaround times and increased accuracy in output are creating lucrative growth opportunities in the market. However, the augmenting costs of several bone diagnostic tests, limited reimbursements, along with limited detection capability are acting as significant factors that are restraining the market growth. On the contrary, the expansion of a wide range of point-of-care (POC) diagnostic tests and a considerable rise in public awareness toward preventive healthcare is creating a positive outlook for the market. The market is further driven by favorable initiatives undertaken by the government and non-profit organizations for promoting awareness about various diagnostic test procedures among the masses. Apart from this, the growing geriatric population that is more susceptible to developing these ailments is leading to the increasing incidences of bone disorders. Some of the other factors contributing to the market include rapid urbanization, rising medical expenditure, new product launches by the manufacturers, and extensive research and development (R&D) activities.

Key Market Segmentation:

Product Insights

Assays/Consumables

Instruments

Test Type Insights

Enzyme-Linked Immunosorbent Assay (ELISA)

Clinical Laboratory Improvement Amendments (CLIA)

Others

Application Insights

Vitamin D Testing

Bone Metabolism

Regional Insights

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for bone and mineral diagnostic testing. Some of the factors driving the North America bone and mineral diagnostic testing market include the expanding geriatric population, rising healthcare expenditure, extensive research and development (R&D) activities conducted by key players, etc.

Competitive Landscape

The report has also provided a comprehensive analysis of the competitive landscape in the global bone and mineral diagnostic testing market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, bioMerieux SA, DiaSorin S.p.A., Epitope Diagnostics Inc., F. Hoffmann-La Roche AG, QuidelOrtho Corporation, Siemens Healthineers AG (Siemens AG), etc.

Key Questions Answered in This Report:

  • How has the global bone and mineral diagnostic testing market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global bone and mineral diagnostic testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive bone and mineral diagnostic testing markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the application?
  • What is the competitive structure of the global bone and mineral diagnostic testing market?
  • Who are the key players/companies in the global bone and mineral diagnostic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bone and Mineral Diagnostic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Assays/Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Enzyme-Linked Immunosorbent Assay (ELISA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinical Laboratory Improvement Amendments (CLIA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Vitamin D Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Bone Metabolism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 bioMerieux SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DiaSorin S.p.A.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Epitope Diagnostics Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 F. Hoffmann-La Roche AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 QuidelOrtho Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Siemens Healthineers AG (Siemens AG)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Bone and Mineral Diagnostic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Bone and Mineral Diagnostic Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Test Type (in %), 2024
  • Figure 6: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Bone and Mineral Diagnostic Testing (Assays/Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Bone and Mineral Diagnostic Testing (Assays/Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Bone and Mineral Diagnostic Testing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Bone and Mineral Diagnostic Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Bone and Mineral Diagnostic Testing (Enzyme-Linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Bone and Mineral Diagnostic Testing (Enzyme-Linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Bone and Mineral Diagnostic Testing (Clinical Laboratory Improvement Amendments (CLIA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Bone and Mineral Diagnostic Testing (Clinical Laboratory Improvement Amendments (CLIA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Bone and Mineral Diagnostic Testing (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Bone and Mineral Diagnostic Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Bone and Mineral Diagnostic Testing (Vitamin D Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Bone and Mineral Diagnostic Testing (Vitamin D Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Bone and Mineral Diagnostic Testing (Bone Metabolism) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Bone and Mineral Diagnostic Testing (Bone Metabolism) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia-Pacific: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia-Pacific: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: Bone and Mineral Diagnostic Testing Market: Breakup by Country (in %), 2024
  • Figure 70: Middle East and Africa: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: Bone and Mineral Diagnostic Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 72: Global: Bone and Mineral Diagnostic Testing Industry: Value Chain Analysis
  • Figure 73: Global: Bone and Mineral Diagnostic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bone and Mineral Diagnostic Testing Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 4: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Bone and Mineral Diagnostic Testing Market: Competitive Structure
  • Table 7: Global: Bone and Mineral Diagnostic Testing Market: Key Players